Fig. 1
a Magnetic Resonance Imaging (MRI) scan in March 2018 after treatment with a PD-1 inhibitor. b MRI scan showing smaller lesions in May 2018 after treatment with Sorafenib
Fig. 1 | Journal for ImmunoTherapy of Cancer
a Magnetic Resonance Imaging (MRI) scan in March 2018 after treatment with a PD-1 inhibitor. b MRI scan showing smaller lesions in May 2018 after treatment with Sorafenib